Epigenetic Regulation via MBD2 Silencing
Corresponding Organization :
Other organizations : Centre de Recherche en Cancérologie de Lyon, Centre Léon Bérard, Université Claude Bernard Lyon 1, Inserm, Centre National de la Recherche Scientifique, Roslin Institute, University of Edinburgh, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Nantes Université, Centre International de Recherche sur le Cancer, Institut d'Investigació Biomédica de Bellvitge
Variable analysis
- CAF-CM treatment
- MBD2 siRNA treatment
- DAC treatment
- Cell count or proliferation
- MBD2 expression or knockdown
- Cell seeding density (1.10^5 and 3.10^5 per well in six-well plates)
- Treatment duration (48 h for CAF-CM, 72 h for MBD2 siRNA, and 3 days for DAC)
- Cell culture conditions (six-well plates)
- Negative control: Control siRNA (Sigma-Aldrich, MISSION siRNA Universal Negative Controls #1)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!